Business

United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key Players - Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb

Opportunities in the U.S. multiple myeloma market include leveraging cutting-edge therapies like targeted treatments and immunotherapies, capitalizing on aging demographics, increasing disease awareness, and investing in oncology research. Expansion in combination treatments also offers significant potential. U.S. Multiple Myeloma Market U.S. Multiple Myeloma Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Multiple Myeloma Market Size, Insights, Analysis, Growth Potential and

articleSanofi SaNovember 3, 20256/company/sanofi-sa-1/news/united-states-multiple-myeloma-market-research-report-2025-2033-profiles-of-key-players-novartis-abbvie-sanofi-johnson-and-johnson-baxter-pfizer-takeda-and-bristol-myers-squibb
United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key Players - Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb

About this update from Sanofi Sa

[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Opportunities in the U.S. multiple myeloma market include leveraging cutting-edge therapies like targeted treatments and immunotherapies, capitalizing on aging demographics, increasing disease awareness, and investing in oncology research. Expansion in combination treatments also offers significant potential.","length":310,"tagName":"p"},{"type":"text","content":"U.S. Multiple Myeloma Market","length":28,"tagName":"p"},{"type":"image","alt":"U.S. Multiple Myeloma Market","displaySize":"","headline":null,"caption":"U.S. Multiple Myeloma Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/f0ad8df6a5e435cb735622670df8b993"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QC4.K0jYuZsLNGWJgOSADg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f0ad8df6a5e435cb735622670df8b993","width":600,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/RO76OjI9HV_H1G_wex5l3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f0ad8df6a5e435cb735622670df8b993","width":600,"height":400}}},{"type":"text","content":"Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Multiple Myeloma Market Size, Insights, Analysis, Growth Potential and Forecasts 2025-2033" report has been added to ResearchAndMarkets.com's offering.","length":227,"tagName":"p"},{"type":"text","content":"The United States multiple myeloma market is poised for remarkable growth, projected to hit US$...

More updates from Sanofi Sa

Multiple MyelomaU.S.market dynamicsJohnson and Johnsonmarket segments